Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential.

D'souza N, Burns JS, Grisendi G, Candini O, Veronesi E, Piccinno S, Horwitz EM, Paolucci P, Conte P, Dominici M.

Adv Biochem Eng Biotechnol. 2013;130:209-66. doi: 10.1007/10_2012_150.

PMID:
22990585
2.

Mesenchymal stem cell secretome and regenerative therapy after cancer.

Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD.

Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Review.

3.

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F.

PLoS One. 2009;4(4):e4992. doi: 10.1371/journal.pone.0004992. Epub 2009 Apr 7. Erratum in: PLoS One. 2013; 8(3). doi:10.1371/annotation/4ab4c130-16cb-41f0-9507-b00ce070fbc6.

4.

Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts.

Covas DT, Panepucci RA, Fontes AM, Silva WA Jr, Orellana MD, Freitas MC, Neder L, Santos AR, Peres LC, Jamur MC, Zago MA.

Exp Hematol. 2008 May;36(5):642-54. doi: 10.1016/j.exphem.2007.12.015. Epub 2008 Mar 4.

PMID:
18295964
5.

Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

Brune JC, Tormin A, Johansson MC, Rissler P, Brosjö O, Löfvenberg R, von Steyern FV, Mertens F, Rydholm A, Scheding S.

Int J Cancer. 2011 Jul 15;129(2):319-30. doi: 10.1002/ijc.25697. Epub 2010 Dec 1.

6.

A fat option for the pig: hepatocytic differentiated mesenchymal stem cells for translational research.

Brückner S, Tautenhahn HM, Winkler S, Stock P, Dollinger M, Christ B.

Exp Cell Res. 2014 Feb 15;321(2):267-75. doi: 10.1016/j.yexcr.2013.10.018. Epub 2013 Nov 4.

PMID:
24200501
7.

Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.

Wu R, Liu G, Bharadwaj S, Zhang Y.

Methods Mol Biol. 2013;1001:65-80. doi: 10.1007/978-1-62703-363-3_7.

PMID:
23494421
8.

Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.

Li CY, Wu XY, Tong JB, Yang XX, Zhao JL, Zheng QF, Zhao GB, Ma ZJ.

Stem Cell Res Ther. 2015 Apr 13;6:55. doi: 10.1186/s13287-015-0066-5.

9.

Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential.

Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A.

Stem Cell Rev. 2013 Feb;9(1):32-43. doi: 10.1007/s12015-012-9365-8.

10.

Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells.

Fotia C, Massa A, Boriani F, Baldini N, Granchi D.

Cytotechnology. 2015 Dec;67(6):1073-84. doi: 10.1007/s10616-014-9731-2. Epub 2014 May 6.

PMID:
24798810
11.

Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells.

Jakob M, Hemeda H, Janeschik S, Bootz F, Rotter N, Lang S, Brandau S.

Stem Cells Dev. 2010 May;19(5):635-44. doi: 10.1089/scd.2009.0245.

PMID:
19761404
12.

Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood.

Rossignoli F, Caselli A, Grisendi G, Piccinno S, Burns JS, Murgia A, Veronesi E, Loschi P, Masini C, Conte P, Paolucci P, Horwiz EM, Dominici M.

Biomed Res Int. 2013;2013:901821. doi: 10.1155/2013/901821. Epub 2013 Mar 31.

13.

In vitro mesenchymal trilineage differentiation and extracellular matrix production by adipose and bone marrow derived adult equine multipotent stromal cells on a collagen scaffold.

Xie L, Zhang N, Marsano A, Vunjak-Novakovic G, Zhang Y, Lopez MJ.

Stem Cell Rev. 2013 Dec;9(6):858-72. doi: 10.1007/s12015-013-9456-1.

14.

Cellular kinetics of perivascular MSC precursors.

Chen WC, Park TS, Murray IR, Zimmerlin L, Lazzari L, Huard J, Péault B.

Stem Cells Int. 2013;2013:983059. doi: 10.1155/2013/983059. Epub 2013 Aug 19. Review.

15.

Bone marrow-derived mesenchymal stem cells and the tumor microenvironment.

Bergfeld SA, DeClerck YA.

Cancer Metastasis Rev. 2010 Jun;29(2):249-61. doi: 10.1007/s10555-010-9222-7. Review.

PMID:
20411303
16.

Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells.

Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R.

BMC Cell Biol. 2014 Dec 20;15:46. doi: 10.1186/s12860-014-0046-0.

17.

Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.

Barcellos-de-Souza P, Comito G, Pons-Segura C, Taddei ML, Gori V, Becherucci V, Bambi F, Margheri F, Laurenzana A, Del Rosso M, Chiarugi P.

Stem Cells. 2016 Jun 14. doi: 10.1002/stem.2412. [Epub ahead of print]

PMID:
27300750
18.

Integral therapeutic potential of bone marrow mesenchymal stem cells.

Kan I, Melamed E, Offen D.

Curr Drug Targets. 2005 Feb;6(1):31-41. Review.

PMID:
15720211
19.

Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials.

Noël D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B.

Exp Cell Res. 2008 Apr 15;314(7):1575-84. doi: 10.1016/j.yexcr.2007.12.022. Epub 2008 Jan 12.

PMID:
18325494
20.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG.

Cytotherapy. 2011 Sep;13(8):918-32. doi: 10.3109/14653249.2011.579957. Epub 2011 Jun 22.

PMID:
21696238
Items per page

Supplemental Content

Write to the Help Desk